The peptide ψTnI derived from PKCδ and cTnI inhibited the cTnI interaction with and phosphorylation by PKCδ, preventing tissue injury in an ex vivo model of myocardial infarction and attenuating ischemia-reperfusion injury-induced mitochondrial dysfunction [115]. The gene discussed is PRKCD; the disease is ischemia.